Managing Treatment Side Effects and Quality of Life
Devan MOODLEY
Where do we stand in developing radionuclides against molecular markers overexpressed on breast cancer (BC) cells such as EGFR-family members?
Willy Wangu
nuclear medicine, Johannesburg, South Africa
Thoracic metastatic manifestations of Breast Cancer.
Asma ZIDI
Radiologist, Tunis, Tunisia
HER2-Targeted Therapies: Beyond Trastuzumab
Hassan GHAZAL
Overview of high-risk patient screening.
Dana HADDAD